IP Library › Granted Patent US 7,655,464
Granted Patent B2
US 7,655,464 · App. 12/409,285 · Granted Feb 2, 2010

Dual inhibitors of HIV-1 GP-120 interactions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,464
App. No.
12/409,285
Granted
Feb 2, 2010
Kind
B2
Abstract

Compounds, which inhibit the binding of gp120 to CD4 as well as 17b and methods for their use in inhibiting the HIV fusion process, are provided.

Claims (3)

1. An isolated peptide consisting of SEQ ID NO: 2 or SEQ ID NO: 3.

2. A composition comprising the peptide of claim 1 .

3. A method of inhibiting the binding of HIV to cell surface receptor CD4, said method comprising contacting cells infected with HIV with the composition of claim 2 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 16, 2022
From: DREXEL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 059022/0665 →
MERGER Recorded Jan 14, 2015
From: PHILADELPHIA HEALTH & EDUCATION CORPORATION
To: DREXEL UNIVERSITY
Reel/Frame 034764/0236 →